- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 271/12 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 271/12
Total number of patents in this class: 205
10-year publication summary
14
|
19
|
10
|
22
|
10
|
20
|
11
|
11
|
9
|
6
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Agios Pharmaceuticals, Inc | 200 |
8 |
Vertex Pharmaceuticals Incorporated | 1581 |
7 |
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 157 |
7 |
The University of Queensland | 666 |
7 |
University of Georgia Research Foundation, Inc. | 972 |
6 |
The Salk Institute for Biological Studies | 436 |
5 |
Bristol-myers Squibb Company | 5080 |
4 |
Merck Patent GmbH | 5909 |
4 |
Taisho Pharmaceutical Co., Ltd. | 844 |
4 |
Toyama Chemical Co., Ltd. | 114 |
4 |
The Johns Hopkins University | 5377 |
3 |
China Pharmaceutical University | 236 |
3 |
Emory University | 1498 |
3 |
Ewha University-industry Collaboration Foundation | 617 |
3 |
Forma Therapeutics, Inc. | 164 |
3 |
Mitobridge, Inc. | 58 |
3 |
Treventis Corporation | 17 |
3 |
Universidad de Zaragoza | 188 |
3 |
Firmenich Incorporated | 124 |
3 |
National University Corporation Tokai National Higher Education and Research System | 543 |
3 |
Other owners | 119 |